Age, Biography and Wiki

Harold S. Koplewicz was born on 12 January, 1953 in Crown Heights, Brooklyn, is a Child psychiatrist.

Popular As N/A
Occupation Child psychiatrist
Age 67 years old
Zodiac Sign Capricorn
Born 12 January 1953
Birthday 12 January
Birthplace Crown Heights, Brooklyn

Harold S. Koplewicz Height, Weight & Measurements

At 67 years old, Harold S. Koplewicz height not available right now. We will update Harold S. Koplewicz’s Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.

Physical Status
Height Not Available
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don’t have much information about He’s past relationship and any previous engaged. According to our Database, He has no children.

Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Harold S. Koplewicz Net Worth

His net worth has been growing significantly in 2019-2020. So, how much is Harold S. Koplewicz worth at the age of 67 years old? Harold S. Koplewicz’s income source is mostly from being a successful . He is from American. We have estimated Harold S. Koplewicz’s net worth, money, salary, income, and assets.

Net Worth in 2020 $1 Million – $5 Million
Salary in 2019 Under Review
Net Worth in 2019 Pending
Salary in 2019 Under Review
House Not Available
Cars Not Available
Source of Income

Harold S. Koplewicz Social Network

Wikipedia Harold S. Koplewicz Wikipedia



After leaving NYU in 2009 Koplewicz started the Child Mind Institute. Two CSC board members left with Koplewicz to serve as co-chairs of his new board of directors. Koplewicz serves as the medical director of the clinic, president of the foundation, and practices on a limited basis.


In 2007, an advertising campaign for the Child Study Center raised objections over its use of simulated ransom notes, seemingly addressed to parents of autistic children. The campaign was abandoned.


In 2001 Koplewicz was one of 22 co-authors of a study referred to as study 329, a drug trial sponsored by GlaxoSmithKline (GSK), that looked at the safety of the use of psychotropic antidepressant drug Paxil (Paroxetine) and concluded that Paxil “is generally well-tolerated and effective for major depression in adolescents” (p. 762). The report and conclusions were then used by GSK to market the drug to children. In October 2011 the company was sued by the United States Department of Justice (DOJ) for false claims and for a fraudulent scheme to deceive and defraud, and charged that the company for touted the study 329 and journal article “that it paid to have drafted and that exaggerated Paxil’s efficacy while downplaying risks identified in one of the trials.” In the summer of 2012 GSK settled the lawsuit with the DOJ for a record $3 billion (and more recently the State of North Carolina for $32 million).


In 1997 he helped found and served as the first director of the NYU Child Study Center (CSC), a position he held until he left NYU in October 2009. He received a severance package in excess of $1.2 million. Koplewicz served as the chairman of the board of a medical devices company called Delcath from 2007 to 2011. While Koplewicz worked at NYU Langone, he also served as the director of the Nathan S. Kline Institute for Psychiatric Research, a psychiatric facility run by the state of New York. In 2011 Koplewicz was dismissed from this role following a dispute with Jeffrey A. Sachs, the newly installed advisor on health care issues to the Governor.

He has received a number of industry awards, including the 1997 Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill, the 1998 Reiger Service Award from the American Academy of Child and Adolescent Psychiatry in recognition of his work in the development of school-based mental health programs, the 1999 Humanitarian Award from Marymount Manhattan College, the 2000 American Grand Hope Award from the Aprica Childcare Institute, the 2002 Catcher in the Rye Award from the American Academy of Child and Adolescent Psychiatry, the 2007 Irving Philips Award for Prevention, the 2009 American Psychiatric Association McAlpin Award for lifetime contributions to child psychiatry, and the 2010 American Society for Adolescent Psychiatry William Schonfeld Award.


According to The New York Times in 1996, Koplewicz was:


Koplewicz has edited orauthored more than 65 peer-reviewed articles and chapters on child and adolescent psychiatry. He is also the editor, author or contributor to several books, including the textbook Depression in Children and Adolescents (Hardwood, 1993); It’s Nobody’s Fault: New Hope and Help for Difficult Children and their Parents; Childhood Revealed: Art Expressing Pain, Discovery & Hope; Turbulent Times, Prophetic Dreams: Art of Palestinian and Israeli Children (2000); More Than Moody: Recognizing and Treating Adolescent Depression; and The Day Our World Changed: Children’s Art of 9/11.


Harold Samuel Koplewicz (born January 12, 1953) is a New York City-based psychiatrist. He is the medical director of a medical clinic, president of a foundation he launched in 2009, director in two development-stage pharmaceutical and medical device companies, and editor-in-chief of the Journal of Child and Adolescent Psychopharmacology.